Ian F. Smith
2017
In 2017, Ian F. Smith earned a total compensation of $5.9M as EVP & Chief Operating Officer at Vertex Pharmaceuticals, a 3% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,339,770 |
|---|---|
| Option Awards | $1,110,263 |
| Salary | $848,077 |
| Stock Awards | $2,625,016 |
| Other | $13,110 |
| Total | $5,936,236 |
Smith received $2.6M in stock awards, accounting for 44% of the total pay in 2017.
Smith also received $1.3M in non-equity incentive plan, $1.1M in option awards, $848.1K in salary and $13.1K in other compensation.
Rankings
In 2017, Ian F. Smith's compensation ranked 1,491st out of 14,666 executives tracked by ExecPay. In other words, Smith earned more than 89.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,491 out of 14,666 | 90th |
Division Manufacturing | 502 out of 5,770 | 91st |
Major group Chemicals And Allied Products | 134 out of 2,074 | 94th |
Industry group Drugs | 97 out of 1,730 | 94th |
Industry Pharmaceutical Preparations | 76 out of 1,329 | 94th |
Source: SEC filing on April 17, 2018.
Smith's colleagues
We found six more compensation records of executives who worked with Ian F. Smith at Vertex Pharmaceuticals in 2017.
2017
Jeffrey Leiden
Vertex Pharmaceuticals
Chief Executive Officer
2017
Michael Parini
Vertex Pharmaceuticals
EVP & Chief Legal and Administrative Officer
2017
David Altshuler
Vertex Pharmaceuticals
Chief Scientific Officer
2017
Amit Sachdev
Vertex Pharmaceuticals
EVP & Chief Regulatory Officer
2017
Stuart Arbuckle
Vertex Pharmaceuticals
EVP & Chief Commercial Officer
2017
Thomas Graney
Vertex Pharmaceuticals